Simulations Plus Past Earnings Performance
Past criteria checks 1/6
Simulations Plus has been growing earnings at an average annual rate of 5.7%, while the Healthcare Services industry saw earnings growing at 2.8% annually. Revenues have been growing at an average rate of 13.2% per year. Simulations Plus's return on equity is 5.9%, and it has net margins of 16.3%.
Key information
5.7%
Earnings growth rate
2.3%
EPS growth rate
| Healthcare Services Industry Growth | 1.7% |
| Revenue growth rate | 13.2% |
| Return on equity | 5.9% |
| Net Margin | 16.3% |
| Last Earnings Update | 29 Feb 2024 |
Recent past performance updates
Recent updates
Why We're Not Concerned About Simulations Plus, Inc.'s (NASDAQ:SLP) Share Price
Mar 29
Capital Allocation Trends At Simulations Plus (NASDAQ:SLP) Aren't Ideal
Feb 09Simulations Plus: Questionable Whether It Will Benefit Or Be Hurt By Generative AI
Feb 01We Like Simulations Plus' (NASDAQ:SLP) Earnings For More Than Just Statutory Profit
Jan 12Capital Allocation Trends At Simulations Plus (NASDAQ:SLP) Aren't Ideal
Nov 06Estimating The Intrinsic Value Of Simulations Plus, Inc. (NASDAQ:SLP)
Sep 06Here's What's Concerning About Simulations Plus' (NASDAQ:SLP) Returns On Capital
Jun 28Some Investors May Be Worried About Simulations Plus' (NASDAQ:SLP) Returns On Capital
Feb 10With EPS Growth And More, Simulations Plus (NASDAQ:SLP) Makes An Interesting Case
Nov 23A Look At The Intrinsic Value Of Simulations Plus, Inc. (NASDAQ:SLP)
Oct 21Here's What's Concerning About Simulations Plus' (NASDAQ:SLP) Returns On Capital
Sep 19Simulations Plus goes ex-dividend tomorrow
Jul 21Simulations Plus Q3 2022 Earnings Preview
Jul 05Simulations Plus (NASDAQ:SLP) Might Be Having Difficulty Using Its Capital Effectively
Jun 08Estimating The Fair Value Of Simulations Plus, Inc. (NASDAQ:SLP)
Mar 02Simulations Plus: Software For The Pharma Industry, Significant Upside Potential
Mar 01This Is Why We Think Simulations Plus, Inc.'s (NASDAQ:SLP) CEO Might Get A Pay Rise Approved By Shareholders
Feb 05Be Wary Of Simulations Plus (NASDAQ:SLP) And Its Returns On Capital
Jan 18Are Simulations Plus, Inc. (NASDAQ:SLP) Investors Paying Above The Intrinsic Value?
Nov 24The Returns On Capital At Simulations Plus (NASDAQ:SLP) Don't Inspire Confidence
Oct 11Calculating The Intrinsic Value Of Simulations Plus, Inc. (NASDAQ:SLP)
Aug 17Simulations Plus: Growth Speculation, Buy The Dip In This Drug Testing Company
Aug 01Revenue & Expenses BreakdownBeta
How Simulations Plus makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 29 Feb 24 | 65 | 11 | 31 | 5 |
| 30 Nov 23 | 62 | 11 | 31 | 5 |
| 31 Aug 23 | 60 | 10 | 31 | 5 |
| 31 May 23 | 56 | 10 | 31 | 4 |
| 28 Feb 23 | 54 | 10 | 29 | 4 |
| 30 Nov 22 | 53 | 11 | 27 | 3 |
| 31 Aug 22 | 54 | 12 | 25 | 3 |
| 31 May 22 | 52 | 12 | 23 | 4 |
| 28 Feb 22 | 50 | 12 | 21 | 4 |
| 30 Nov 21 | 48 | 10 | 21 | 4 |
| 31 Aug 21 | 46 | 10 | 21 | 4 |
| 31 May 21 | 46 | 12 | 17 | 4 |
| 28 Feb 21 | 46 | 11 | 17 | 4 |
| 30 Nov 20 | 43 | 10 | 16 | 3 |
| 31 Aug 20 | 42 | 9 | 16 | 3 |
| 31 May 20 | 40 | 9 | 16 | 3 |
| 29 Feb 20 | 38 | 9 | 14 | 3 |
| 30 Nov 19 | 36 | 9 | 13 | 2 |
| 31 Aug 19 | 34 | 9 | 12 | 3 |
| 31 May 19 | 33 | 8 | 11 | 2 |
| 28 Feb 19 | 31 | 7 | 10 | 2 |
| 30 Nov 18 | 30 | 9 | 10 | 2 |
| 31 Aug 18 | 30 | 9 | 10 | 2 |
| 31 May 18 | 29 | 9 | 9 | 2 |
| 28 Feb 18 | 27 | 8 | 9 | 2 |
| 30 Nov 17 | 26 | 6 | 8 | 1 |
| 31 Aug 17 | 24 | 6 | 8 | 1 |
| 31 May 17 | 22 | 5 | 7 | 1 |
| 28 Feb 17 | 21 | 5 | 7 | 1 |
| 30 Nov 16 | 21 | 5 | 7 | 1 |
| 31 Aug 16 | 20 | 5 | 7 | 1 |
| 31 May 16 | 20 | 5 | 7 | 2 |
| 29 Feb 16 | 20 | 5 | 7 | 2 |
| 30 Nov 15 | 19 | 4 | 7 | 1 |
| 31 Aug 15 | 18 | 4 | 7 | 1 |
| 31 May 15 | 17 | 4 | 6 | 1 |
| 28 Feb 15 | 14 | 3 | 5 | 1 |
| 30 Nov 14 | 13 | 3 | 5 | 1 |
| 31 Aug 14 | 11 | 3 | 4 | 1 |
| 31 May 14 | 11 | 3 | 4 | 1 |
| 28 Feb 14 | 10 | 3 | 4 | 1 |
| 30 Nov 13 | 10 | 3 | 4 | 1 |
| 31 Aug 13 | 10 | 3 | 4 | 1 |
| 31 May 13 | 10 | 3 | 4 | 1 |
Quality Earnings: SLP has a large one-off loss of $4.8M impacting its last 12 months of financial results to 29th February, 2024.
Growing Profit Margin: SLP's current net profit margins (16.3%) are lower than last year (19.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SLP's earnings have grown by 5.7% per year over the past 5 years.
Accelerating Growth: SLP's earnings growth over the past year (0.5%) is below its 5-year average (5.7% per year).
Earnings vs Industry: SLP earnings growth over the past year (0.5%) did not outperform the Healthcare Services industry 15.4%.
Return on Equity
High ROE: SLP's Return on Equity (5.9%) is considered low.